Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells
Abstract Metabolic reprogramming and its molecular underpinnings are critical to unravel the duality of cancer cell function and chemo-resistance. Here, we use a constraints-based integrated approach to delineate the interplay between metabolism and epigenetics, hardwired in the genome, to shape tem...
Guardado en:
Autores principales: | Selva Rupa Christinal Immanuel, Avinash D. Ghanate, Dharmeshkumar S. Parmar, Ritu Yadav, Riya Uthup, Venkateswarlu Panchagnula, Anu Raghunathan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1e7865ffc7db435cb53c095773f326ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas RP, et al.
Publicado: (2012) -
Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma
por: D. M. Tiek, et al.
Publicado: (2018) -
Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
por: Tae Hoon Roh, et al.
Publicado: (2020) -
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
por: Xiaoyue Chen, et al.
Publicado: (2018) -
Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide
por: Yiming Ding, et al.
Publicado: (2021)